Andres Yarur, MD

Cedars-Sinai Medical Center
Los Angeles, CA

Disclosure information not submitted.

Presentation(s):

• B0387 - Baseline Demographics and Disease Characteristics of Patients With Ulcerative Colitis Who Responded to Vedolizumab at Week 6

  Monday, October 24, 2022
  10:00 AM – 12:00 PM ET

• B0385 - Patients With High Visceral Adipose Tissue Burden Have a Higher Target Therapeutic Infliximab Concentrations: Should We Be Filling the VAT?

  Monday, October 24, 2022
  10:00 AM – 12:00 PM ET

• B0386 - Real World Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-Naïve Patients With Crohn’s Disease: Results From the EVOLVE Study

  Monday, October 24, 2022
  10:00 AM – 12:00 PM ET

• B0084 - The Association Between Stool Shedding of SARS-Cov-2, Microbiome Diversity and Intestinal Inflammation

  Monday, October 24, 2022
  10:00 AM – 12:00 PM ET